Match to clinical trials in 60 seconds
- Know your options
- Access the latest treatments
- Receive world class care
AbbVie Clinical Trials - Migraine
Adolescents:
- Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
- A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Adults:
- Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine
- Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
- Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
Pfizer Clinical Trials - Migraine
Lundbeck Clinical Trials - Migraine
Teva Migraine Pregnancy Registry
Teva Migraine Pregnancy Registry
The Teva Migraine Pregnancy Registry studies the effects of migraine medications during pregnancy. Eligible participants (ages 18-45) can join by completing a short screening. No extra medical visits required.
MRI Brain Study of Migraine
UNC-Chapel Hill School of Medicine is recruiting 201 adults (18+) from three groups (67 in each group):
- Adults with migraine taking anti-CGRP medications
- Adults with migraine who are not taking anti-CGRP medications
- Adults with no history of migraine
Enrolling now through September 2026